$SNPS

Dear Synopsys Stock Fans, Mark Your Calendars for August 26

Synopsys (SNPS) reported Q2 FY2026 revenue of $2.3B, up 41.9% YOY, beating estimates. Adjusted EPS was $3.35, down 8.7% YOY but above forecasts. Non-GAAP net income rose 12.4% YOY. The company raised full-year guidance, targeting $9.665B in revenue and $14.72-$14.80 in non-GAAP EPS. Analysts rate SNPS 'Strong Buy' with an average price target of $560, implying 35.5% upside.

Original reporting
Published Aug 19, 2026, 8:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 8:29 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Dear Synopsys Stock Fans, Mark Your Calendars for August 26 — source image
Decision brief

The 30-second read

$SNPSBullishHigh
01

Why it matters

The earnings beat and raised guidance may trigger re-rating by analysts and increased institutional buying.

02

Market read

Earnings and guidance lift Synopsys and may lift the broader EDA sector.

03

What to watch

Potential margin pressure from higher R&D spend and competitive pricing.

Relevance 9/10Novelty 9/10Timing: post-earnings release

Background

Synopsys is a leading provider of electronic design automation software, recently expanding AI capabilities.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys reported Q2 FY2026 earnings with revenue up 41.9% YoY and raised FY2026 revenue guidance to $9.665B.

Expected impact

Potential price appreciation as investors price in higher revenue outlook.

Evidence & confidence

Guidance beat and revenue growth exceed expectations, likely to drive buying pressure.

Market effects

Boosts outlook for the EDA sector and AI-driven design tools.

Positive for US tech stocks and related supply-chain players.

Reinforces demand for semiconductor design software worldwide.

Counterpoint

If guidance falls short of market expectations, the stock could face a pullback.

Key entities

  • Synopsys

    Electronic design automation (EDA) software provider.

Related articles

$SNPSMedAI 8/10

Why Has Synopsys Stopped Leading With Bad News?

Synopsys (SNPS) shifted its earnings call focus from past issues, like China's export restrictions and IP business underperformance, to new growth areas like Multiphysics Fusion with Ansys and agentic AI. Design Automation grew to $7.7-7.9B, while Design IP remained at $1.8B. Management expects new initiatives to boost EDA growth in 2027, but Design IP's turnaround is based on a single quarter of growth.

$SNPSMed

SNPS Upgraded by Morgan Stanley -- Price Target Maintained at $5

Morgan Stanley upgraded Synopsys (SNPS) to Overweight, maintaining a $500 price target. The stock is trading at $396.11, which is 39.9% undervalued according to its GF Value™ of $659.20. Synopsys has a GF Score™ of 88/100, indicating strong growth potential but concerns about valuation. Insider activity shows significant selling, with $40.7 million in sales over the last three months.

$SNPSMedAI 9/10

How to Play SNPS Stock as Layoffs Hit Synopsys

Synopsys (SNPS) reported Q3 FY2026 earnings with revenue of $2.48B, up 42.4% YoY, and EPS of $3.91, beating estimates. The company raised its full-year outlook. Analysts maintain 'Buy' ratings with price targets up to $633, citing long-term growth potential in semiconductor design.